Value of EUS-guided parenchymal liver biopsy. A randomized controlled trial.

Not Applicable

• Conditions: K74; K71; Fibrosis and cirrhosis of liver; Toxic liver disease

• Registration Number: DRKS00028038
• Lead Sponsor: Elisabeth-Krankenhaus Essen, Abteilung für Gastroenterologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-02-04
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 96

Inclusion Criteria

Written consent, elevated liver enzymes, need for staging of viral, autoimmune or metallic liver disease.

Exclusion Criteria

Age<18 years, pregnancy, acquired or kongenital hemophilia, no written consent, low platelets<50000/microl, INR>1.5, Limited capacity for consent.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Periinterventional pain measured with the numeric pain score.

Secondary Outcome Measures

Name	Time	Method
Complication rate, length of biopsy core, Count of Portal Fields, Count of biopsy cores, allover length of all biopsy cores, technical success.